- Home
- LSAK vs BNTC Comparison
LSAK vs BNTC Comparison
Compare LSAK & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- BNTC
- Stock Information
- Founded
- LSAK 1997
- BNTC 1995
- Country
- LSAK South Africa
- BNTC United States
- Employees
- LSAK N/A
- BNTC N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- LSAK Finance
- BNTC Health Care
- Exchange
- LSAK Nasdaq
- BNTC Nasdaq
- Market Cap
- LSAK 344.5M
- BNTC 335.5M
- IPO Year
- LSAK N/A
- BNTC N/A
- Fundamental
- Price
- LSAK $4.74
- BNTC $13.24
- Analyst Decision
- LSAK
- BNTC Strong Buy
- Analyst Count
- LSAK 0
- BNTC 5
- Target Price
- LSAK N/A
- BNTC $26.00
- AVG Volume (30 Days)
- LSAK 18.6K
- BNTC 40.8K
- Earning Date
- LSAK 09-10-2025
- BNTC 09-25-2025
- Dividend Yield
- LSAK N/A
- BNTC N/A
- EPS Growth
- LSAK N/A
- BNTC N/A
- EPS
- LSAK N/A
- BNTC N/A
- Revenue
- LSAK $574,080,000.00
- BNTC N/A
- Revenue This Year
- LSAK $1.06
- BNTC N/A
- Revenue Next Year
- LSAK $13.32
- BNTC N/A
- P/E Ratio
- LSAK N/A
- BNTC N/A
- Revenue Growth
- LSAK 4.13
- BNTC N/A
- 52 Week Low
- LSAK $3.39
- BNTC $8.06
- 52 Week High
- LSAK $5.60
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- LSAK 51.59
- BNTC 59.72
- Support Level
- LSAK $4.60
- BNTC $12.57
- Resistance Level
- LSAK $4.76
- BNTC $13.33
- Average True Range (ATR)
- LSAK 0.11
- BNTC 0.60
- MACD
- LSAK -0.01
- BNTC 0.10
- Stochastic Oscillator
- LSAK 36.73
- BNTC 95.59
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.